0001365916-22-000072.txt : 20220701
0001365916-22-000072.hdr.sgml : 20220701
20220701164543
ACCESSION NUMBER: 0001365916-22-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220701
DATE AS OF CHANGE: 20220701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELSEY NICOLE
CENTRAL INDEX KEY: 0001714653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 221062061
MAIL ADDRESS:
STREET 1: AMYRIS, INC.
STREET 2: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
wf-form4_165670832552138.xml
FORM 4
X0306
4
2022-06-30
0
0001365916
AMYRIS, INC.
AMRS
0001714653
KELSEY NICOLE
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
0
1
0
0
CHIEF LEGAL OFFICER- SECRETARY
Common Stock
2022-06-30
4
S
0
94033
1.8017
D
63333
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as part of personal liquidity planning for tax purposes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.765 to $1.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
/s/ Nicole Kelsey
2022-07-01